From a longer-term and more sustainable perspective, repurposing various natural compounds such as hinokitiol as prophylactic agents with immuno-modulatory effects and a favorable impact on cancer control [69] may complement SNHG5–GNB2-directed strategies, particularly in settings with limited access to complex biologics or in patients at high risk of recurrence after resection. Here, GNB2 is linked to cancer.